CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 24th, 2008 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 24th, 2008 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2008 (this “Agreement”), is entered into by and among LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Buyer”), PHARMACOPEIA, INC., a Delaware corporation (“Target”), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 23rd, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • New York
Contract Type FiledDecember 23rd, 2008 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2008 (this “Agreement”), is entered into by and among LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Buyer”), PHARMACOPEIA, INC., a Delaware corporation (“Target”), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 26th, 2008 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 26th, 2008 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [—], 200[—] (this “Agreement”), is entered into by and among LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Buyer”), PHARMACOPEIA, INC., a Delaware corporation (“Target”), and [—], a [—], as Rights Agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).